R&G PHARMASTUDIES revenue breakdown overview

R&G PHARMASTUDIES revenue for the last year amounted to 744.00 M CNY, the most of which — 319.97 M CNY — came from its highest performing source at the moment, Clinical Trial Operation, the year earlier bringing 354.49 M CNY. The greatest contribution to the revenue figure was made by China — last year it brought R&G PHARMASTUDIES 664.58 M CNY, and the year before that — 674.39 M CNY.